|
|
Volumn 50, Issue SUPPL. 1, 1993, Pages 35-52
|
|
The case for mitomycin in non-small cell lung cancer
|
|
Author keywords
Avoidance of mitomycin associated toxicity; Mitomycin; Mitomycin in combined modality therapy; Mitomycin associated toxicity; Non small cell lung cancer
|
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
CORTICOSTEROID;
DEXAMETHASONE;
DOXORUBICIN;
FLUOROURACIL;
MITOMYCIN;
VINBLASTINE;
VINCA ALKALOID;
VINDESINE;
ADULT RESPIRATORY DISTRESS SYNDROME;
BLOOD VESSEL INJURY;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER STAGING;
CARDIOTOXICITY;
CONFERENCE PAPER;
DRUG ACTIVITY;
DRUG EFFICACY;
FOLLOW UP;
HEMOLYTIC UREMIC SYNDROME;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOPENIA;
LUNG EDEMA;
LUNG INJURY;
LUNG LOBECTOMY;
LUNG NON SMALL CELL CANCER;
LUNG TOXICITY;
OXYGEN BREATHING;
OXYGEN CONCENTRATION;
PERIOPERATIVE PERIOD;
PRIORITY JOURNAL;
RESPIRATORY FAILURE;
SMOKING CESSATION;
SURVIVAL TIME;
THROMBOSIS;
THROMBOTIC THROMBOCYTOPENIC PURPURA;
|
|
EID: 0027157693
PISSN: 00302414
EISSN: None
Source Type: Journal
DOI: 10.1159/000227246 Document Type: Conference Paper |
|
Times cited : (29)
|
|
References (0)
|
